Through the open door: Preferential binding of dasatinib to the active form of BCR-ABL unveiled by in silico experiments-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Through the open door: Preferential binding of dasatinib to the active form of BCR-ABL unveiled by in silico experiments

Published:2013-06-15 Issue:5 Volume:7 Page:968-975
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:

Author:

Laurini Erik,Posocco Paola,Fermeglia Maurizio,Gibbons Don L.,Quintás-Cardama Alfonso,Pricl Sabrina

Funder

ESTECO

European Commission – DG Research in the 7th Framework Program

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1016/j.molonc.2013.06.001/fullpdf

Reference26 articles.

1. Activation of tyrosine kinases by mutation of the gatekeeper threonine;Azam;Nat. Struct. Mol. Biol.,2008

2. Case , D.A. Darden , T.A. Cheatham , T.E. 2010 Amber 11 University of California San Francisco, USA

3. How I treat newly diagnosed chronic phase CML;Cortes;Blood,2012

4. The development of imatinib as a therapeutic agent for chronic myeloid leukemia;Deininger;Blood,2005

5. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia;Druker;N. Engl. J. Med.,2006

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insight into the Basic Mechanisms and Various Modulation Strategies Involved in Cancer Drug Resistance;Current Cancer Drug Targets;2023-11

2. Ligandability and druggability assessment via machine learning;WIREs Computational Molecular Science;2023-06-04

3. Styrylquinazoline derivatives as ABL inhibitors selective for different DFG orientations;Journal of Enzyme Inhibition and Medicinal Chemistry;2023-04-18

4. Molecular Implications of BCR-ABL1 in Hematological Malignancies;Reference Module in Biomedical Sciences;2023

5. Comparison of molecular responses and outcomes between BCR::ABL1 e14a2 and e13a2 transcripts in chronic myeloid leukemia;Cancer Science;2022-08-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3